This is an automated coin monitor, not investment advice.
Stellar (XLM)
USD 0.1669
USD 0.6342
-73.7%
Stage 4 (Downtrend)
Bullish factors: golden cross, MACD+
Bearish factors: price < 50d, price < 200d, 50d falling, RSI weak (40.8), falling 1m & 3m, far below high, strong bear trend (ADX 30.3), vol 1.3x on down day, distribution (OBV down, vol ratio 0.82)
Low: USD 0.0908
Now: USD 0.1669
Technical Snapshot
| RSI (14) | 40.8 | ADX (14) | 30.3 |
| 50d MA | USD 0.1919 | 200d MA | USD 0.1832 |
| Price vs 50d | ▼ Below | Price vs 200d | ▼ Below |
| Support | USD 0.1572 | Resistance | USD 0.2125 |
| ATR Volatility | 4.56%/day | Model state | Bearish trend |
Crypto Performance Comparison
| Asset | 1 Month | 3 Months | 6 Months | 1 Year |
| XLM | -8.7% | -9.4% | -3.9% | +5.1% |
| BTC | -2.3% | -1.3% | +33.9% | +21.8% |
| ETH | -1.2% | -3.9% | +53.4% | +24.9% |
| SOL | -8.3% | -7.1% | +37.1% | +17.8% |
Trend-Following Backtest
2-year simulation on a notional USD 15,000 starting balance using the model’s 50d/200d MA crossover + RSI filter. The model goes long when price is above a rising 50d MA with RSI 40-75, and goes flat on a death cross or RSI above 82. Hypothetical, before fees and slippage.
Strategy vs Buy & Hold
| Asset | Strategy | Buy & Hold | Max DD | Trades | Win Rate |
| XLM | -34.7% | -41.7% | -45.7% | 40 | 38% |
DCA vs Lump Sum (XLM)
Hypothetical result of a notional USD 15,000 placed one year ago under different timing schedules. Simulation only, not a recommendation.
| Strategy | Return | Value Today |
| Lump Sum (1y ago) | +5.1% | USD 9,295 |
| DCA — 4 buys | -3.8% | USD 14,436 |
| DCA — 6 buys | -13.7% | USD 12,951 |
| DCA — 12 buys | -12.8% | USD 13,073 |
Levels the system watches
Reference levels used by the trend model to classify XLM. They describe how the model reads the chart, not what anyone should do.
| Support (recent swing low) | USD 0.1572 |
| Resistance (recent swing high) | USD 0.2125 |
| Trend model’s invalidation level (ATR-based) | USD 0.1517 (-9.1% from current price) |
| ATR (14) | USD 0.007617 (4.56%/day) |
| Price location vs trend (model label) | Pullback |
The invalidation level is where the model would stop treating the current trend reading as valid (roughly 2x ATR below price or 0.5x ATR below the recent swing low, whichever is lower). It is a model parameter, not a stop-loss recommendation.
Backtest Trade Log
| Date | Action | Price | Simulated P&L |
| 2026-09-12 | BUY | USD 0.1801 | |
| 2026-09-13 | SELL | USD 0.1771 | -1.6% |
| 2026-09-14 | BUY | USD 0.1912 | |
| 2026-09-15 | SELL | USD 0.1761 | -7.9% |
| 2026-09-16 | BUY | USD 0.1836 | |
| 2026-09-17 | SELL | USD 0.1835 | -0.1% |
| 2026-09-18 | BUY | USD 0.1931 | |
| 2026-09-19 | SELL | USD 0.1962 | +1.6% |
| 2026-09-20 | BUY | USD 0.1973 | |
| 2026-10-08 | SELL | USD 0.1920 | -2.7% |
| 2026-10-11 | BUY | USD 0.2029 | |
| 2026-10-12 | SELL | USD 0.1906 | -6.1% |
Trend-following methodology: 50d/200d MA crossover + RSI filter + ADX regime gate · Backtests are hypothetical and exclude fees.
RSI 40.8 and ADX at 30.3 while price sits under the 50d at 0.1919. that ADX reading means the downtrend actually has strength behind it, this isnt drifting, its trending
support at 0.1572 is barely 6% below spot and the ATR is 4.56% a day. one bad candle and that level is gone, the MACD bullish cross is noise at this range
ATR alone eats that 0.1572 support in a day and a half, fully agree. watching the 0.15 psych level instead
0.15 has held twice this year already. third test with ADX this hot is usually the one that breaks
third test breaking is the textbook read with adx this hot. alerts at 0.15 and patience is the entire strategy this quarter
the macd bull cross getting dismissed at this range is correct, that signal fires constantly inside stage 4 trends. alerts at 0.15 and boredom is the strategy
macd bull cross defenders keep getting proven wrong, six failed retests and hot adx. 0.12 is the only level left that matters
ADX 30 with rsi 40.8 is the one combo i actually respect. trying to front run this before 0.15 is knife catching
0.15 is the line for me too. under it theres nothing but air till 0.12
0.12 has the 2023 base structure under it so theres a floor down there somewhere. but yeah everything between here and 0.15 is knife catching in slow motion
that combo with a 4.56% daily atr means wide stops and small size, otherwise you get wicked out before the actual move
wide stops plus a bearish bias equals watching from the sidelines, honestly the cheapest position on xlm right now
XLM up 5.1% on the year while BTC did 21.8% and ETH 24.9%. holding since the 0.6342 high takes a special kind of patience
5.1 on the year and im still holding from 0.41. at this point xlm is a savings account that pays in disappointment
0.41 down to 0.1669 is a masterclass in opportunity cost. the 2023 base near 0.12 is where the real hold or fold decision happens
hold or fold at 0.12 is the honest framing. 0.15 breaking third test with adx this hot probably answers it before the base even gets tested
0.41 entry crew checking in. my average is 0.33 and even i stopped averaging down below 0.17
xlm at 0.1669 with the 50d at 0.1919 overhead. the stretch between here and support is a no trade zone for me, alerts set at 0.15 and nothing else
adx 30 on a downtrend means the trend is the trade. every bounce under the 50d at 0.19 has been a distribution gift
every bounce under 0.1919 sold off within two days this quarter, checked the history. trend followers eat here, hero buyers fund them
six failed retests of 0.19 since september, at some point the market is simply voting on the asset
Six failed retests of 0.19 is not a coin flip anymore, the market has voted six times. Respect the trend until the 0.12 base actually gets tested.
six votes against 0.19 and the monitor still prints a macd bull cross like it matters. 0.12 test or nothing
up 5.1% on the year against btc at 21.8% and the model still finds 6 bullish factors. xlm holders are endurance athletes
0.41 to 0.1669 and the only debate is where the base is. anchoring to 2023 levels near 0.12 feels hopeful, that base was a different market